Exosome Research Market Will Grow at a CAGR of 16.26% 2024-2031

Global  Exosome Research Market is valued at US$ 172.30 Mn in 2023, and it is expected to reach US$ 570.70 Mn by 2031, with a CAGR of 16.26% during the forecast period of 2024-2031.

Exosome research is a fast-expanding topic in molecular biology and health sciences. Exosomes are small extracellular vesicles released by different cell types that play an important role in intercellular communication by transporting proteins, lipids, and nucleic acids between cells. Exosome research and development activities are seeing increased public and private funding, which has supported market expansion.

Download Free Report Sample Pages @ https://www.insightaceanalytic.com/request-sample/1810

Recent Developments:

  • In October 2022, Global Stem Cells Group (GSCG) announced the availability of a new product that uses lyophilized exosome technology. The Global Stem Cells Group's new product line comprises innovative anti-aging therapies that can regenerate cells and tissues in the body.
  • In July 2022, Cells for Cells, a clinical-stage startup pioneering allogeneic stem cell and stem-cell-derived treatments for high-impact chronic diseases, announced a 6-month follow-up of the landmark clinical data from the first patient to receive an exosome-produced therapy for osteoarthritis.
  • In April 2022, Global Stem Cells Group (GSCG) announced the release of a new product featuring lyophilized exosome technology. The Global Stem Cells Group's new product line includes breakthrough anti-aging therapies capable of regenerating cells and tissues in the body.